RHB Research's top pick is IHH, premised on its defensive demand, with diversified presence and anticipated operational recovery from its lagging markets (Malaysia and Singapore). (File pic shows IHH's Pantai Hospital in Kuala Lumpur.)
PETALING JAYA: The healthcare sector could still hold potential for those who have yet to buy into the sector.
Healthcare stocks such as IHH Healthcare Bhd
and Duopharma Biotech Bhd (DBB) may still have have further room to run, premised upon new growth drivers and structurally higher cost of care, according to analysts.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
